New York private equity fund to acquire control of Taylormade at a valuation of about $250 million

In depth

The company's platform connects patients in the US with assistance programs for funding medications and receiving medical treatment. According to Globes, the company was founded after a family member's struggle with cancer, and Srulik Dvorsky, the founder and CEO, told Globes: "I knew I wanted to build something even small but useful, and immediately start running and meet the market up close." According to Ice, the Israeli investment fund Almeda Venturers will record a profit of about $5 million from the realization.